Dosing Commenced in Phase IIa PBT2 Trial of Alzheimer's Patients: Financial News - Yahoo! Finance

Dosing Commenced in Phase IIa PBT2 Trial of Alzheimer's Patients: Financial News - Yahoo! Finance: "Prana Biotechnology Limited (Nasdaq: PRAN / ASX: PBT) today announced that dosing has commenced in its Phase IIa clinical trial of PBT2 in patients with early Alzheimer's disease.

ADVERTISEMENT
The PBT2-201-Euro trial is being conducted in seven centers throughout Sweden and will focus on exploring the safety and tolerability of PBT2"